Evaluation of influenza vaccine Vaxigrip in the combined immunization of conscripts during influenza seasons of 2002-2003
The immunization properties of the influenza vaccine Vaxigrip, used in combination with vaccines against pneunococcal infection and hepatitis A (respectively, Pneumo 23 and Avaxim), were evaluated. In Central Russia in one of the units of the internal forces of the RF Ministry of Internal Affairs 3...
Saved in:
Published in | Žurnal mikrobiologii, ėpidemiologii i immunobiologii no. 1; p. 49 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | Russian |
Published |
Russia (Federation)
01.01.2004
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | The immunization properties of the influenza vaccine Vaxigrip, used in combination with vaccines against pneunococcal infection and hepatitis A (respectively, Pneumo 23 and Avaxim), were evaluated. In Central Russia in one of the units of the internal forces of the RF Ministry of Internal Affairs 3 groups totaling 755 servicemen were formed, depending on the complex of the introduced vaccines. Active medical observation and the registration of the complaints of the vaccinees at the postvaccinal period did not reveal unusual reactions and complications in none of the groups under observation. In the evaluation of the level of specific antibodies to the circulating influenza viruses prior to vaccination the low level of collective protection to influenza B virus was determined: protective antibody levels were registered only in 14-18% of the servicemen, while the corresponding data with respect of influenza viruses A(H1N1) and A(H3N2) were 45-50% and 56-63% respectively. At the same time, in seronegative persons the vaccine Vaxigrip exhibited high immunogenic activity with respect of all 3 influenza strains; seroconversion to them was determined in 84-92% of the vaccines, and the level of protective antibody titers before the beginning of the epidemic season was 86-99% in the whole of the group. The characteristics of the prophylactic effectiveness of the vaccine Vaxigrip in relation to the influenza virus infection level 1 were 4.7 (index) and 79% (coefficient). In addition, the frequency of influenza cases, clinically pronounced and confirmed by laboratory methods, in patients who had been immunized with 3 vaccines was 6.7%, which was 10.3 times less frequent than number of cases in the groups of comparison (68.2% on the average). The coefficient of epidemiological effectiveness of the prophylaxis of influenza was 90.2%. The complex use of 3 preparations did not affect the immunization properties of the vaccine Vaxigrip. |
---|---|
AbstractList | The immunization properties of the influenza vaccine Vaxigrip, used in combination with vaccines against pneunococcal infection and hepatitis A (respectively, Pneumo 23 and Avaxim), were evaluated. In Central Russia in one of the units of the internal forces of the RF Ministry of Internal Affairs 3 groups totaling 755 servicemen were formed, depending on the complex of the introduced vaccines. Active medical observation and the registration of the complaints of the vaccinees at the postvaccinal period did not reveal unusual reactions and complications in none of the groups under observation. In the evaluation of the level of specific antibodies to the circulating influenza viruses prior to vaccination the low level of collective protection to influenza B virus was determined: protective antibody levels were registered only in 14-18% of the servicemen, while the corresponding data with respect of influenza viruses A(H1N1) and A(H3N2) were 45-50% and 56-63% respectively. At the same time, in seronegative persons the vaccine Vaxigrip exhibited high immunogenic activity with respect of all 3 influenza strains; seroconversion to them was determined in 84-92% of the vaccines, and the level of protective antibody titers before the beginning of the epidemic season was 86-99% in the whole of the group. The characteristics of the prophylactic effectiveness of the vaccine Vaxigrip in relation to the influenza virus infection level 1 were 4.7 (index) and 79% (coefficient). In addition, the frequency of influenza cases, clinically pronounced and confirmed by laboratory methods, in patients who had been immunized with 3 vaccines was 6.7%, which was 10.3 times less frequent than number of cases in the groups of comparison (68.2% on the average). The coefficient of epidemiological effectiveness of the prophylaxis of influenza was 90.2%. The complex use of 3 preparations did not affect the immunization properties of the vaccine Vaxigrip. |
Author | Burtseva, E I Shevchenko, E S Artiukov, R M Rybin, V V Vlasova, L N Sabanin, Iu V Slepushkin, A N Tarasevich, N N Rikhter, V V |
Author_xml | – sequence: 1 givenname: E I surname: Burtseva fullname: Burtseva, E I organization: Ivanovsky Research Institute of Virology, Military Medical Command, Ministry of Internal Affairs, Moscow, Russia – sequence: 2 givenname: L N surname: Vlasova fullname: Vlasova, L N – sequence: 3 givenname: E S surname: Shevchenko fullname: Shevchenko, E S – sequence: 4 givenname: Iu V surname: Sabanin fullname: Sabanin, Iu V – sequence: 5 givenname: V V surname: Rikhter fullname: Rikhter, V V – sequence: 6 givenname: R M surname: Artiukov fullname: Artiukov, R M – sequence: 7 givenname: V V surname: Rybin fullname: Rybin, V V – sequence: 8 givenname: N N surname: Tarasevich fullname: Tarasevich, N N – sequence: 9 givenname: A N surname: Slepushkin fullname: Slepushkin, A N |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15024982$$D View this record in MEDLINE/PubMed |
BookMark | eNpNUNlqwzAQ1ENKc7S_UPQDBmnlS48lpAcE8hL6GnSsUhVbNpYdmnx9FXrQl51lZnYWZklmoQs4IwsmKsik4HxOljF-MJZzKfJbMucFg1zWsCDnzUk1kxp9F2jnqA-umTBcFD0pY3xA-qY-_XHwfZLo-I7UdK1OvKW-bafgL3-npgvRJOMYqZ0GH47_wiKqmOSrDRiDLA1xR26caiLe_-CK7J82-_VLtt09v64ft1lf5JBpp5Xm0oDg1mk0ojbXHaSziHVpqtJCJbU0yJC7yqJgSpQF54XgmF7Bijx8x_aTbtEe-sG3ajgffiuAL6nEWn4 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Opyt primeneniia grippoznoĭ vaktsiny Vaksigrip pri sochetannoĭ immunizatsii prizyvnikov srochnoĭ sluzhby v épidemicheskom sezone 2002-2003 gg |
ExternalDocumentID | 15024982 |
Genre | Controlled Clinical Trial Comparative Study Clinical Trial English Abstract Journal Article |
GeographicLocations | Russia |
GeographicLocations_xml | – name: Russia |
GroupedDBID | 123 AELAQ ALMA_UNASSIGNED_HOLDINGS CGR CUY CVF ECM EIF F5P GROUPED_DOAJ NPM VCL VIT VME |
ID | FETCH-LOGICAL-p542-bfbab19c231dfbec38cc23129fdee86c76d279b9ce0e1f7de30a36511531e0022 |
ISSN | 0372-9311 |
IngestDate | Wed Oct 09 10:28:04 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | Russian |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p542-bfbab19c231dfbec38cc23129fdee86c76d279b9ce0e1f7de30a36511531e0022 |
PMID | 15024982 |
ParticipantIDs | pubmed_primary_15024982 |
PublicationCentury | 2000 |
PublicationDate | 2004 Jan-Feb |
PublicationDateYYYYMMDD | 2004-01-01 |
PublicationDate_xml | – month: 01 year: 2004 text: 2004 Jan-Feb |
PublicationDecade | 2000 |
PublicationPlace | Russia (Federation) |
PublicationPlace_xml | – name: Russia (Federation) |
PublicationTitle | Žurnal mikrobiologii, ėpidemiologii i immunobiologii |
PublicationTitleAlternate | Zh Mikrobiol Epidemiol Immunobiol |
PublicationYear | 2004 |
SSID | ssj0041934 |
Score | 1.5927649 |
Snippet | The immunization properties of the influenza vaccine Vaxigrip, used in combination with vaccines against pneunococcal infection and hepatitis A (respectively,... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 49 |
SubjectTerms | Adult Alphainfluenzavirus - immunology Antibodies, Viral - blood Betainfluenzavirus - immunology Hepatitis A - immunology Humans Influenza Vaccines - administration & dosage Influenza, Human - blood Influenza, Human - immunology Influenza, Human - prevention & control Male Military Personnel Pneumococcal Vaccines - administration & dosage Russia Vaccination Vaccines, Inactivated - administration & dosage Viral Vaccines - administration & dosage |
Title | Evaluation of influenza vaccine Vaxigrip in the combined immunization of conscripts during influenza seasons of 2002-2003 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/15024982 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwELUKCIkLYt-RD_RUBbWJsx2hFBUEPRXEDcWxA1FFUkGDoF_AZzP2ZBObgEsU2Y4TZZ6dN5NZCDmwLeFYUjqG6fquwYBzGNxknsGFGTEg7KHFVTTy5cDpX7HzG_um0XireS1lE34YTr-MK_mPVKEN5KqiZP8g2XJSaIBzkC8cQcJw_JWMe2Wqbsz8oOuNTIPWcxCq_-Wt6-AlvoNdoXBmhGcARRgoZqyjQqblpaAU4_bxVMQtVpMpK2LuLKdrlCg_szqlbXbt5vEJ0tqHeFTkdYq1m4Diqr5bVaGN41aMdy-HlQaB7HECn2lNZnuVMfca6H2KrRe1_0b38hngloxSHF4VEwt4kGBehLMs9-AtjBqsZtTIg7lc0_CtTucTBHGfxTSnNRGPH7SMgd6CPonljH7u_ZBlu-iaITOup3bKgbL64BedAcnFNGT5Q-laTjj-gzaiWclwiSzm6gQ9Qmwsk8ZjtkLmscDo6yp5rRBC04iWQqU5QmiBEOiigBBaIITWEaIurRBCESG1yXKEqGElQtbI8LQ37PaNvNiGMbaZafCIBxyWJtB9EcG6trxQnZt-JKT0nNB1BKxm7oeyLTuRK6TVDiwH2Drs4VIRwXUym6SJ3FTOch0hTduKmKcSygnuOqCEh37bE5wJm22RDXxlt2NMqHJbvMztb3t2yEIFk10yF8EKlntAByd8X8vqHWrWY9c |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+influenza+vaccine+Vaxigrip+in+the+combined+immunization+of+conscripts+during+influenza+seasons+of+2002-2003&rft.jtitle=%C5%BDurnal+mikrobiologii%2C+%C4%97pidemiologii+i+immunobiologii&rft.au=Burtseva%2C+E+I&rft.au=Vlasova%2C+L+N&rft.au=Shevchenko%2C+E+S&rft.au=Sabanin%2C+Iu+V&rft.date=2004-01-01&rft.issn=0372-9311&rft.issue=1&rft.spage=49&rft_id=info%3Apmid%2F15024982&rft_id=info%3Apmid%2F15024982&rft.externalDocID=15024982 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0372-9311&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0372-9311&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0372-9311&client=summon |